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Treatment of ~~~~~~~~ I vis membranes with the 2’,3’-dialdehyde of GTP (dial GTP) drastically inhibits 
their adenylyt cycfase activity. Optimal inhibition is obtained by treatment with 1 mM diat GTP for Ih at 
32°C. Using guanyi-5’-yl imidodiphosphate, F-, forskoiin and Mn2+ as activators of the enzyme it can be 
concluded that dial GTP preferentially reacts with the stimulatory subunit (NJ and slightly with the catalyt- 
ic subunrt. Dial GTP treatment greatly reduces the inhibition of adenylyl cyclase by progesterone. Pure 
exogenuus N, stimulates the enzyme but does not restore progesterone inhibition. Treatment with dial 
f@P]GTP labels several membrane proteins some of which have simifar M, to N, and N,. 
Guanine nucleotides play an important role in 
the hormonal regulation of membrane-bound 
adenylyl cyclase. The evidence gathered in recent 
years indicates that two guanine nucleotide binding 
proteins are involved in m~duiat~ng the activity of 
the catalytic subunit of the enzyme. Stimulatory 
hormones appear to activate a 43-kDa membrane 
protein (N,) which binds GTP or GDP and which 
can be ADP-ribasyIated by choIera toxin. Most in- 
hibitory hormones, on the other hand, seem to 
function through a similar GTPIGDP binding 
. 4 
Abbrev~atrons: N,, stimulatory guanine nucleotide 
binding component that regulates adenylyt cyctases; N,, 
inhibitory guanine nucleotide bmding component that 
regufates adenylyl cyclases; Gpp(NH)p, guanyl-5’-yl im- 
idodiphosphate; App(NHfp, adenyl-5 ’-yf imidodiphos- 
phate; dial GTP or dial ATP, the 2,’ 3’ dialdehyde of the 
nucleotide triphosphate 
* To whom correspondence should be addressed 
protein that can be ADP-rib~s~lated by pertussis 
toxin and has an M,=41000 (reviews [l,Zj). 
The adenylyl cyclase present in Xcnopus h&s 
oocytes has been shown to contain both N, and Nt 
type subunits [3,4], but is unusual on two counts: 
it is the only known adenyfyl cyclase regulated by 
a steroid hormone, since it is inhibited by physio- 
logical concentrations of progesterone 15-71; and 
its inhibition does not seem to be mediated by Nt 
[3,4]. The inhibition requires the presence of 
guanine nucleotides [7] and the hormone affects 
the kinetics of the activation of the enzyme by 
Gpp(N~)p [S], a known activator of N,. Un this 
basis, our current hypothesis proposes that pro- 
gesterone inhibition may interfere with the N, ac- 
tivation of the catalytic subunit of the enzyme. 
We have now studied the effect of treatment of 
the membrane-bound adenyfyf cyclase with the 
2’ ,3 ‘-dialdehyde of GTP (dial GTP) prepared by 
periodate oxidation of GTP. Dial ATP and dial 
GTP have been used to react with and inhibit en- 
zymes that have high affinity for the correspond- 
ing nucfeotide triphosphates and which have reac- 
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tive amino groups in the vicinity of the binding 
sites [9,10]. The Schiff base that forms between the 
protein amino group and one of the carbonyls of 
the 2’ ,3 ‘-dialdehyde of the nucleotide triphosphate 
can be stabilized by borohydride reduction. Dial 
ATP followed by reduction with NaCNBH3 has 
been demonstrated to inhibit irreversibly the 
catalytic subunit of the enzyme [ 1 I]. 
The results presented below show that reaction 
of the membranes with dial GTP preferentially in- 
activates the N, protein that mediates guanine 
nucleotide and fluoride stimulation of adenylyl 
cyclase. The catalytic subunit, as measured with 
forskolin and Mn2+, is slightly affected by dial 
GTP. The reaction of the membrane with the dial 
GTP almost completely eliminates the inhibition 
of the adenylyl cyclase by progesterone. This in- 
hibition by the hormone cannot be restored by ad- 
ditional exogenous N,. Using radioactive dial GTP 
it is possible to label several membrane proteins, 
some of which have similar iM, to N, and Ni. 
2. MATERIALS AND METHODS 
2.1. Preparation and assay of adenylyi cyciase 
from X. laevis oocytes 
The isolation of X. iaevis ovarian oocytes and 
the preparation of the membrane fractions that 
contain the major adenylyl cyclase activity were 
carried out exactly as described [3]. The activity of 
the adenylyl cyclase was assayed by the procedure 
of Rodbell 1121, using the method of Solomon et 
al. [13] to purify the [c+~~P]cAMP synthesized. 
Other details have been published [8]. 
2.2. Preparation of the 2 ‘,3 ‘-dialdehyde of GTP 
The synthesis of the 2’ ,3 ’ -dialdehyde of GTP 
was done by the method of Easterbrook-Smith et 
al. [9], using periodate to oxidize the 2 ’ - and 3 ’ - 
of the ribose of the GTP and excess ethylene glycol 
to stop the reaction. The dial GTP was separated 
from the other reaction products by gel filtration 
on Sephadex G-10 and its purity was controlled by 
thin-layer chromatography on polyethyleneimine 
plates developed with 1.2 M LiCI. Dial [c-Y-~‘P]GTP 
was synthesized by first preparing [a-32P]GTP us- 
ing the procedure of Walseth and Johnson [ 141 and 
subsequently ‘going through the oxidation and 
purification steps described above. 
2.3. Treatment of oocyte membranes with dial 
GTP 
The membrane preparations with adenylyl 
cyclase activity described above (15-25 mglml) 
that had been previously washed by resedimenting 
3 times in an Eppendorf microfuge for 10 min in 
a buffer containing 50 mM sodium phosphate buf- 
fer (pH 8.0), 1 mM dithiothreitol and 1 mM EDTA 
were incubated for 1 h with 1 mM dial GTP in a 
buffer containing 50 mM sodium phosphate buffer 
(pH 8.0), 1 mM dithiothreitol, 0.3 mM EDTA, 5% 
glycerol, 5 mM MgCl2, 4 mM creatine phosphate, 
0.4 mg/ml creatine kinase and 5 mM App(NH)p. 
The reaction was stopped by addition of a few 
crystals of NaBH4 and a 5-fold dilution with 50 
mM Hepes, pH 8.0. The membranes were isolated 
again by centrifugation in an Eppendorf microfuge 
for 10 min and washed 3 times by resedimenting in 
the same buffer. Since dial ATP has been shown to 
inactivate the catalytic subunit of adenylyl cyclase 
[I l], it seemed possible that diat GTP could also be 
reacting with the nucleotide triphosphate site of 
the catalytic subunit. To prevent this, the treat- 
ment of the membranes was carried out routinely 
in the presence of 5 mM App(NH)p, which should 
protect ATP sites and has the advantage of being 
resistant o ATPases present in the membranes. 
2.4. Other techniques and sources of materials 
SDS-polyacrylamide gels and autoradiography 
were carried out as described by Laemmli [15] and 
previously detailed [3]. [c-~~P]ATP was prepared 
as described by Walseth and Johnson [14] using 
32P purchased from the Chilean Atomic Energy 
Commission. t3H]cAMP was purchased from New 
England Nuclear. Progesterone and forskolin were 
obtained from Calbiochem. Gpp(NH)p, ATP, 
GTP and CAMP were from Sigma. Pure human 
erythrocyte N, was obtained as described by 
Codina et al. [16] and was a kind gift from Dr 
Birnbaumer. 
3. RESULTS 
3.1. The effect of dial GTP treatment of oocyte 
membranes on the activity of adenylyl cyclase 
Fig.lA shows the effect of pretreating oocyte 
membranes with different concentrations of dial 
GTP on the activity of the adenylyl cyclase mea- 
sured in the presence or absence of Gpp(NH)p. It 
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Fig. 1. Inhibition of adenylyl cyclase by treatment of oocyte membranes with dial GTP. (A) Membranes were treated 
with the concentrations specified of dial GTP for 1 h by the procedure detailed in section 2. Subsequently the adenylyl 
cyclase activity was measured in the presence of 25 PM Gpp(NH)p (@--o) or without this guanine nucleotide (M) 
using 120 pg membrane protein as described in section 2. (B) Treatment of the membranes with 1 mM dial GTP was 
carried out at 32°C for different periods of time and the adenylyl cyclase activity was measured in the presence of 25 
,uM Gpp(NH)p. The control value of 0 time treatment, which was taken as 100% activity, was 22 pmol CAMP pro- 
duced/mg membrane protein. 
is clear that concentrations of dial GTP above 0.1 
mM greatly inhibit the activation of the enzyme 
caused by GPP(NH)P without affecting the basal 
activity of the enzyme. The activation of adenylyl 
cyclase by Gpp(NH)p is mediated by N,. Fig.lB 
shows that the inhibition of N, by treatment of the 
membranes with dial GTP is a time-dependent pro- 
cess that approaches completion after 60 min in- 
cubation. Similar results were obtained using the 
2’ ,3 ‘-dialdehyde of GDP (not shown). The speci- 
ficity of the inhibition caused by dial GTP was 
determined by measuring the activity of the mem- 
branes in the presence of several activators of 
adenylyl cyclase, as shown in table 1. In the control 
tubes the membranes were pre-incubated in the 
presence of an equal concentration of unmodified 
GTP. It has been shown [17] that GTP has a 
negligible effect on the oocyte adenylyl cyclase and 
that only the non-hydrolyzable analogues of GTP 
are able to stimulate the enzyme. It can be seen in 
table 1 that the most pronounced inhibition caused 
by the dial GTP involves Gpp(NH)p (79%) and 
fluoride (62070), both of which are known to act 
through N,. It is also important to note that the 
presence of an equal amount of unmodified GTP 
during the treatment significantly reduces the in- 
hibition caused by the dial GTP on the enzyme ac- 
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tivated by Gpp(NH)p. Forskolin, a diterpene drug 
which is known to activate mainly the catalytic 
subunit, is also inhibited, but to a lesser degree 
than the N, activators. Mn’+, which is known to 
function exclusively through activation of the 
catalytic subunit, is not significantly inhibited and 
is therefore similar to the basal activity. 
3.2. Effect of dial GTP on the inhibition of the 
adenylyl cyclase by progesterone 
The oocyte adenylyl cyclase that is stimulated by 
guanine nucleotides can be strongly inhibited by 
micromolar concentrations of progesterone. The 
data presented in table 2 show that dial GTP treat- 
ment of the membranes, in addition to greatly 
reducing the activation of Gpp(NH)p, almost com- 
pletely eliminates the inhibition caused by pro- 
gesterone. Since the evidence indicated that the 
dial GTP was preferentially inactivating the N, 
subunit of the membrane, an experiment was per- 
formed to determine the effect of adding increas- 
ing concentrations of exogenous untreated pure N, 
from human erythrocytes (fig.2). The addition of 
exogenous N, to the membranes treated with the 
dial GTP (dashed lines) in the presence of 
Gpp(NH)p increases the activity 3-fold. However, 
progesterone inhibits the adenylyl cyclase activity 
Volume 185, number 1 FEBS LETTERS 
Table 1 
Effect Of dial GTP treatment of membranes on the stimulation Of 
adenylyl cyclase by different activators 
Nucleotide used Activator Adenylyl cyclase % inhibition 
to treat present in assay activity (pm01 caused by dial 
membranes cAMP/mg protein) GTP 
None none 4.3 _ 
GTP none 4.8 _ 
Dial GTP none 4.6 4 
GTP GPP(NH)P 85.1 _ 
Dial GTP GPP(NH)P 18.0 79 
Dial GTP + 
GTP GPP(NH)P 40.0 53 
GTP forskolin 110.0 - 
Dial GTP forskolin 67.4 39 
GTP fluoride 78.7 - 
Dial GTP fluoride 30.3 62 
GTP Mn2+ 22.0 _ 
Dial GTP Mn” 20.2 10 
Treatment of the membranes with dial GTP or with GTP in the con- 
trol tubes was carried out as described in section 2, always using 1 mM 
of each nucleotide. Gpp(NH)p was used at 15 FM, forskolin at 150 
FM, NaF at 10 mM. In the experiments with Mn*+, the MgClz present 
in the normal assay mixture was replaced by 10 mM MnCl2. The assay 
of adenylyl cyclase was performed as in [8], using 100 fig membrane 
proteins and incubating for 30 min at 32°C. All results presented are 
the averages of triplicate determinations. The % inhibition due to dial 
GTP treatment was calculated using as reference the value obtained 
with the same activator with membranes treated with GTP 
June 1985 
only slightly even in the presence of the added un- membranes. In this case, the inhibition by pro- 
treated N,. Exogenous erythrocyte N, can also gesterone is maintained at a constant absolute 
stimulate the adenylyl cyclase of the untreated value when the N, is limiting as seen by the fact 
aor - 
Fig.2. Effect of addition of exogenous N, on the 
adenylyl cyclase activity of control and dial GTP treated 
membranes with and without progesterone. Pure human 
erythrocyte N, was added to membranes that had been 
pre-treated with 1 mM dial GTP ( A,O,U) or with 1 mM 
GTP (A,O, q ) and re-isolated, and incubated for 30 
min at 4°C in the same buffer used for membrane isola- 
tion. The adenylyl cyclase activity was measured with 
addition of 15 pM Gpp(NH)p, in the presence (A,A) or 
absence (o,o) of 5 FM progesterone. All the assays con- 
tained 75.0,ug membrane protein and the incubations (35 
min) were carried out and processed as described in sec- 
tion 2. The squares at the bottom indicate the basal ac- 
tivity of the enzyme measured in the absence of 
GPP(NH)P. 
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Table 2 
Effect of dial GTP treatment on the inhibition of progesterone of 
adenylyi cyclase stimulated by Gpp(NH)p 
Nucleotide used Additions to Adenylyf cyclase % inhibition 
to treat cyclase assay activity (pmol by progesterone 
membranes cAMP/mg protein) 
GTP none 3.1 _ 
GPP(NH)P 62.8 - 
GPP(NH)P + 
progesterone 29.4 53 
Dial GTP none 
GPP(NH)P 
GPP(NH)P + 
progesterone 
4.0 - 
16.0 - 
14.6 9 
-_ 
The treatment of the membranes using 1 mM GTP or I mM dial GTP 
was as described in section 2. The assay of the adenylyl cyclase was 
carried out as detailed [g], using 100 /rg membrane proteins and 30 
min incubation at 32°C and where specified, I5 PM Gpp(NH)p and 
5 FM progesterone. The % inhibition due to progesterone was 
calculated using as reference the value obtained with the respective 
membranes and Gpp(NH)p 
that the curves with and without the hormone rise 
in parallel. At the highest concentration of exo- 
genous N3, when this protein is apparently in ex- 
cess, the inhibition by progesterone is eliminated. 
67 I(+ 
43K---, 
3OK- 
B 
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3.3. Label@ of membrane proteins with radio- 
active dial GTP 
If the dial GTP is reacting to form covalent 
bonds with membrane proteins, it should be possi- 
ble to label the membrane proteins that interact 
with the guanine nucleotide by using a radioactive 
derivative. The membrane preparations have a 
large number of proteins that can be separated by 
SDS electrophoresis and subsequently stained 
(fig.3A). Fig.3B shows the autoradiograph of these 
oocyte membrane proteins labelled by treatment 
with dial [cx-~~P]GTP and subsequently separated 
- 
Fig.3. Labetling of membrane proteins with dial 
[a-32P]GTP. Membrane proteins (0.3 mg) were incu- 
bated with dial [a-32P]GTP under different conditions. 
Subsequently the membrane proteins were fractionated 
on an SDS-polyacrylamide gel electrophoresis. Channel 
I was loaded with membranes treated with 200pM dial 
[~u-~~P]GTP; in channel 2, 10 mM GTP was present in 
addition to the same amount of dial [(r-‘“P]GTP and in 
channel 3, the membrane proteins had been reacted with 
non-radioactive 1 mM dial GTP for 60 min and washed 
by sedimentation previous to the treatment with the dial 
[u-~‘P]GTP. (A) Membrane proteins stained with 
Coomassie blue, (B) autoradiography of the same gel. 
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by SDS gel electrophoresis. It is evident that 
several proteins are fabelfed by this procedure 
(channel 1) and that the labelling can be prevented 
by carrying out the reaction in the presence of ex- 
cess non-radioactive GTP (channel 2). Labelling 
can also be prevented by previously treating the 
membranes with non-radioactive dial GTP (chan- 
nel 3). The most prominent bands are in the A4, 
range of 65 000 and of 40 000-44 OOO. These latter 
proteins are important since they approximately 
coincide with the M, values of N, and Ni of oocytes 
]3,41. 
4. DISCUSSION 
The results presented above demonstrate that 
treatment of X. Levis oocyte membranes with the 
2’ ,3 ’ -dialdehyde of GTP can affect the activity of 
the adenylyl cycfase present in those membranes. 
The dial GTP clearly acts preferenti~ly on the 
guanine nucleotide-binding site of protein N, as 
evidenced by the fact that GTP protects from inac- 
tivation and that the most pronounced inhibition is 
obtained with Gpp(NH)p and F-, which act 
through N,. 
The dial GTP treatment also diminishes for- 
skofin activation, albeit considerably less than the 
activation obtained with Gpp(NH)p and F-. This 
result is interesting in the light of the fact that for- 
skolin is supposed to act mainly on the catalytic 
subunit of adenyfyf cyclase. It can be contrasted 
with the finding that Mn2+ activation, which is 
also thought to act exclusively on the catalytic 
subunit, is only slightly inhibited by the dial GTP. 
This apparent discrepancy could be resolved if N, 
were to participate in the activation of the catalytic 
subunit by forskolin. A simifar expfanation was 
proposed by Wong and Martin 1181, who obtained 
identical results using GTP-y-azidoanilide on a rat 
liver adenylate cyclase. Other work supporting the 
partial involvement of N, in forskolin activation of 
adenylyl cyclase has also appeared [ 19-211. 
The fact that added exogenous pure N, can 
restore a large part of the activity lost by dial GTP 
treatment of the membranes (fig.3) afso strongly 
supports the idea that this treatment preferentially 
inactivates the endogenous N,. 
The most interesting finding of this work is that 
the treatment of the membranes with the dial GTP 
practically eliminates the inhibition of the adenylyf 
cycfase by progesterone. This finding is very dif- 
ferent from that obtained with phenothiazines, 
which affect the general membrane properties 1221, 
or with proteolytic treatment of the membranes 
[4], both of which cause a drastic decrease of the 
activity of the enzyme, but do not reduce the per- 
cent inhibition by progesterone, This finding lends 
support to our hypothesis that N, is involved in the 
mechanism of action of progesterone inhibition of 
oocyte adenylate cyclase. It also indicates that the 
fraction of N, that most readily reacts with the dial 
GTP is also the fraction of that subunit that is af- 
fected by progesterone inhibition. 
Another important conclusion is that, while ex- 
ogenous N, can activate the catalytic subunit of the 
enzyme, the added protein cannot act as a trans- 
ducer of the hormonal effect. The hormone and its 
receptor must be somehow coupled to the en- 
dogenous N, is a manner that cannot be achieved 
by the exogenous component under the conditions 
tested. Pertinent to these observations are the find- 
ings of Arad et al. [23], who have reported 
evidence to show that the components of the 
adenylyl cyclase are interacting closely in the mem- 
brane. The results obtained with the untreated 
membranes also showed that when an excess ex- 
ogenous N, is added, and presumably the catalytic 
subunit is limiting, the endogenous N, that is 
susceptible to progesterone inhibition can be com- 
peted out. 
The use of dial GTP to label guanine nucleotide 
binding proteins may be useful in identifying ‘G- 
proteins’ and in studying their active residues and 
sites. In addition to the adenylyl cyclase regulatory 
proteins, other GTP and GDP binding proteins 
play key roles in protein synthesis, light transduc- 
tion in the retina, tubulin polymerization [24,25], 
and even in the mechanism of oncogenesis involv- 
ing the ras oncogene [26]. 
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